Literature DB >> 17721736

Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China.

Y Huang1, S Zhuang, M Du.   

Abstract

BACKGROUND: To study risk factors of neonatal nosocomial infection caused by extended-spectrum beta-lactamase (ESBL)-producing bacteria in a neonatal intensive care unit (NICU). PATIENTS AND METHODS: A retrospective cohort study was conducted in a university hospital NICU in south China. Medical records of neonatal nosocomial infection caused by Escherichia coli or Klebsiella pneumoniae were reviewed. Twenty-two neonates infected with ESBL-producing bacteria (case patients) were compared with 17 patients infected with non-ESBL producing strains (controls). Univariable and multivariable logistic regression were performed to analyze risk factors for infection with ESBL-producing strains. The spectrum of antimicrobial resistance of ESBL-positive E. coli or K. pneumoniae was also examined.
RESULTS: Both univariable and multivariable logistic regression analysis revealed that preterm low birth weight, prolonged mechanical ventilation (> or = 7 days) and prior use of third-generation cephalosporins were risks factors for ESBL-producing E. coli or K. pneumoniae infection (p < 0.05), with an odd ratio of 6.43 (95% CI: 1.51-27.44; p = 0.017), 7.50 (95% CI: 1.38-40.88; p = 0.017) and 9.00 (95% CI: 1.65-49.14; p = 0.008) respectively. However, the length of hospital stay before isolation of pathogens, endotracheal intubation, presence of a central venous catheter, days on third-generation cephalosporins and prior use of beta-lactamase inhibitors were not statistically significant (p > 0.05). Resistance of ESBL-positive strains to piperacillin, tobramycin, aztreonam and cephalosporins was significantly higher than that of ESBL-negative ones (p < 0.05). ESBL-producing strains appeared susceptible to carbapenem, fluoroquinolones, and beta-lactamase inhibitor combination piperacillin-tazobactam.
CONCLUSIONS: Preterm low birth weight, prolonged mechanical ventilation and prior use of third-generation cephalosporins are risks factors for nosocomial infection with ESBL-producing bacteria in NICU.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721736     DOI: 10.1007/s15010-007-6356-9

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  17 in total

1.  A high burden of late-onset sepsis among newborns admitted to the largest neonatal unit in central Vietnam.

Authors:  H T Tran; L W Doyle; K J Lee; N M Dang; S M Graham
Journal:  J Perinatol       Date:  2015-07-09       Impact factor: 2.521

2.  Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.

Authors:  Kenneth M Wener; Vered Schechner; Howard S Gold; Sharon B Wright; Yehuda Carmeli
Journal:  Antimicrob Agents Chemother       Date:  2010-03-08       Impact factor: 5.191

Review 3.  Antibiotic resistance in neonatal intensive care unit pathogens: mechanisms, clinical impact, and prevention including antibiotic stewardship.

Authors:  Sameer J Patel; Lisa Saiman
Journal:  Clin Perinatol       Date:  2010-09       Impact factor: 3.430

4.  The Prevalence and Molecular Epidemiology of Multidrug-Resistant Enterobacteriaceae Colonization in a Pediatric Intensive Care Unit.

Authors:  Nuntra Suwantarat; Latania K Logan; Karen C Carroll; Robert A Bonomo; Patricia J Simner; Susan D Rudin; Aaron M Milstone; Tsigereda Tekle; Tracy Ross; Pranita D Tamma
Journal:  Infect Control Hosp Epidemiol       Date:  2016-02-09       Impact factor: 3.254

5.  Bacteriological Profile and Antimicrobial Susceptibility Patterns of Gram-Negative Bloodstream Infection and Risk Factors Associated with Mortality and Drug Resistance: A Retrospective Study from Shanxi, China.

Authors:  Nan Shi; Jianbang Kang; Shuyun Wang; Yan Song; Donghong Yin; Xiaoxia Li; Qian Guo; Jinju Duan; Shuqiu Zhang
Journal:  Infect Drug Resist       Date:  2022-07-06       Impact factor: 4.177

6.  Optimizing the Use of Antibacterial Agents in the Neonatal Period.

Authors:  Joseph B Cantey
Journal:  Paediatr Drugs       Date:  2016-04       Impact factor: 3.022

7.  Frequency and characteristics of infections caused by extended-spectrum beta-lactamase-producing organisms in neonates: a prospective cohort study.

Authors:  Nandini Vijayakanthi; Dheeraj Bahl; Nirmaljit Kaur; Arti Maria; Nand Kishore Dubey
Journal:  Biomed Res Int       Date:  2013-09-24       Impact factor: 3.411

8.  Mode of delivery and other risk factors for Escherichia coli infections in very low birth weight infants.

Authors:  Agnieszka Chmielarczyk; Jadwiga Wójkowska-Mach; Dorota Romaniszyn; Paweł Adamski; Ewa Helwich; Ryszard Lauterbach; Monika Pobiega; Maria Borszewska-Kornacka; Ewa Gulczyńska; Agnieszka Kordek; Piotr B Heczko
Journal:  BMC Pediatr       Date:  2014-10-18       Impact factor: 2.125

9.  Intense intestinal carriage and subsequent acquisition of multidrug-resistant enterobacteria in neonatal intensive care unit in Morocco.

Authors:  Btissam Arhoune; Samira El Fakir; Sara Himri; Kaoutar Moutaouakkil; Salma El Hassouni; Moussa Benboubker; Fouzia Hmami; Bouchra Oumokhtar
Journal:  PLoS One       Date:  2021-06-30       Impact factor: 3.240

10.  Molecular characterization of multidrug-resistant Klebsiella pneumoniae isolates.

Authors:  Xiang-hua Hou; Xiu-yu Song; Xiao-bo Ma; Shi-yang Zhang; Jia-qin Zhang
Journal:  Braz J Microbiol       Date:  2015-07-01       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.